to gene-disease associations. General concerns include the lack of explicit reporting of inclusion and exclusion criteria, a failure to explore possible sources of heterogeneity, and the absence of an investigation of publication bias. An important aspect of the inclusion criteria for a meta-analysis is outcome definition, since differences in the way outcome is defined and measured may well explain heterogeneity of study results. 3, 7 Another important source of heterogeneity is diversity in the populations studied, in particular ethnic diversity. 3 Publication bias arises because studies showing either statistically significant results or large effect sizes are often more likely to be published than negative studies, 8, 9 and thus the result of a meta-analysis based on published studies may be positively biased. Publication bias is particularly important in genetic epidemiology because it is possible to study many polymorphisms on the same subjects and then to select those that are submitted for publication. 3, [10] [11] [12] [13] Although simple graphical methods such as funnel plots can be used to detect publication bias, 8, 9 in the review by Attia et al. 6 only 20% of the meta-analyses (7 out of 37) addressed this issue. Methodological issues that are specific to genetic epidemiology include the checking of Hardy-Weinberg equilibrium and the choice of a genetic model. 6, 7 In the meta-analysis of genetic association studies there are always at least three possible genotypes to compare. This contrasts with the two treatment groups characteristic of most biomedical meta-analyses. In practice, the number of possible comparisons between genotypes is often reduced by assuming a specific genetic model, such as dominant or recessive, but the conclusions might be sensitive to this assumption. 6 In the simplest case of a polymorphism with two alleles (G and g), one of which is thought to be associated with a disease (G), association studies will usually collect information on the numbers of diseased and disease-free subjects with each of the three genotypes (gg, Gg, and GG). To date almost all metaanalyses of genetic association studies have reduced the three groups to two by (i) ignoring the heterozygotes and comparing gg with GG, (ii) performing separate pairwise comparisons, (iii) assuming a recessive model to justify combining the gg and Gg genotypes and comparing gg 1 Gg with GG, (iv) assuming a dominant model and comparing gg with Gg 1 GG, and (v) assuming a per-allele effect that places Gg mid-way between gg and GG, also called the co-dominant model. When unsure about the genetic model, some investigators fit multiple models and/or perform pairwise comparisons. However, adjustment for multiple testing is seldom made, and the pairwise estimates of the odds ratio of GG vs gg (subsequently referred to as OR GG ) and the odds ratio of Gg vs gg (subsequently referred to as OR Gg ) are usually obtained by carrying out two separate meta-analyses, thus ignoring the correlation between the two odds ratios induced by the common baseline group.
The review by Attia et al. 6 showed that 24 of 37 meta-analyses based their analysis on the assumption of an underlying genetic model, with half of these testing multiple modes of inheritance or multiple pairwise comparisons. A biological justification for the choice of the genetic model was provided in only eight metaanalyses. In nine of the meta-analyses the genetic effect was tested by comparing the allele frequency in cases and controls. All of the methods of analysis in common use, with the exception of the pairwise comparisons, make the implicit assumptions that a particular genetic model applies in all studies, and, more importantly, that the model is known in advance; for instance, the gene might be assumed to be recessive in all populations. Here we suggest a genetic model-free approach to the meta-analysis of genetic association studies that also assumes a common genetic model across studies but which does not specify the mode of inheritance in advance. The underlying genetic model is instead estimated from the data. Although no specific genetic model is assumed, the analyses are, of course, still based on an assumed statistical model. The model is based on a simple reparameterization and uses the odds ratio between the homozygous genotypes (OR GG ) to captures the magnitude of the genetic effect, and l, the ratio of log OR Gg and log OR GG, to capture the genetic mode of inheritance. l is assumed to be common across studies, but if this assumption is in doubt then pairwise comparisons obtained using bivariate random-effect meta-analysis methods, which take into account the correlation between OR GG and OR Gg , should be used.
14, 15 We describe graphical and statistical ways of investigating whether the assumption of a common l is reasonable. Allowing l to take any value (unbounded analysis), is equivalent to allowing the possibility of heterosis, i.e. the risk of the Gg group can be higher or lower than either of the homozygous groups. Although rare, heterosis has been described. 16, 17 If this possibility can be excluded on biological grounds then it is better to constrain l between 0 and 1 (bounded analysis); this restricts the mode of effect to the spectrum between dominant, through co-dominant, to recessive.
Methods
Genetic model-free approach: a common but unrestricted genetic model
Consider the meta-analysis of a bi-allelic polymorphism, in which G is the risk allele, and a dichotomous disease outcome is ascertained for each genotype. We define two parameters: the odds ratio between the two homozygous genotypes, OR GG ; and l, the ratio of log OR Gg and log OR GG . The value of l is not restricted, but values equal to 0, 0.5, and 1 correspond to the recessive, co-dominant, and dominant genetic model, respectively, and values .1 or ,0 would suggest positive or negative heterosis. Log OR GG could be modelled as a fixed-effect or as a random effect that allows for heterogeneity across studies. 8 In the analyses presented, the log OR GG has been modelled as a random effect except in those situations where the heterogeneity of log OR GG was very close to 0. l is modelled as a fixed-effect, that is, the genetic model is assumed to be the same in all studies. It is usually not possible to model both log OR GG and l as random effects because, without extra information, it is very difficult to disentangle the heterogeneity of l from that of log OR GG . The two log odds ratios from each study are modelled as being bivariate normally distributed. The within study variances and covariances are obtained from the reports of the individual studies and are treated as known. Any heterogeneity is assumed to be normally distributed. Full details of the model are reported in the Appendix. In the examples presented the parameters were estimated by maximum likelihood using the ml command in Stata. 18 19 with the best models showing the smallest AIC.
Prior to model fitting, it may be useful to plot, for each study, the log OR Gg vs log OR GG , as shown in Figure 1 , in which the slope of the association between logOR Gg and log OR GG represents l. Such a plot may help check the consistency of l across studies and identify outlying studies. Study-specific estimates of l and bootstrapped 95% confidence intervals (CIs), as shown in Figure 2 , help assess whether the variation in l across studies might be explained by sampling error. Figure 2 is based on 1000 bootstrap samples from each study. If the genetic model does not seem to be consistent across studies then it may be better to perform joint pairwise comparisons using a general bivariate meta-analysis model, 14 which does not assume that l is common but still takes into account the correlation between OR GG and OR Gg . Details of this model are also given in the Appendix.
Examples
The genetic model-free approach is illustrated using five published examples of the meta-analysis of genetic association studies. For each meta-analysis, the number of studies included, frequency of the risk allele, methods used by their authors, and main reported results, are given in Table 1 .
ACE gene and diabetic nephropathy
This meta-analysis was carried out to evaluate the controversial association of the I/D polymorphism of the ACE gene with diabetic microangiopathy (nephropathy and retinopathy). 20 Here we consider only the meta-analysis assessing the effect on nephropathy. A dominant model was assumed and 21 studies were pooled to give an odds ratio of 1.32 (95% CI 1.15-1.51). The average allele frequency for the genetic variant was 0.46.
KIR6.2 gene and Type II diabetes
The K1 inwardly rectifier (KIR) channel is a protein that plays a major role in glucose-stimulated insulin secretion. Its encoding gene, KIR6.2, has been suggested as a candidate for inherited defects in Type II diabetes. This meta-analysis was carried out assuming dominant, recessive, and co-dominant models with Pvalues corrected for multiple testing. 21 The result of the metaanalysis, based on four studies, was a significant association between KIR6.2 and Type II diabetes. The average frequency for the risk allele was 0.34.
AGT gene and essential hypertension
The genetic variant Thr235 of the angiotensinogen (AGT) gene has been found to be associated with hypertension in some linkage and association studies. This meta-analysis of seven Japanese case-control studies reported an odds ratio for the Thr235 allele of 1.22 (95% CI 1.05-1.42), with an average allele frequency of 0.75. 22 
MTHFR gene and coronary heart disease
The 677C!T is a polymorphism of the MethyleneTetraHydroFolate Reductase (MTHFR) gene involved in folate metabolism, which causes elevated homocysteine levels and has been associated with an increased risk of coronary heart disease. This metaanalysis of 49 studies reported an odds ratio of 1.21 (95% CI 1.06-1.39) for the TT vs CC comparison, 23 in close agreement with another meta-analysis published around the same time. 24 The average frequency for the T allele was 0.32.
PON1 Q192R polymorphism and myocardial infarction
PON1 is one of the genes encoding for paraoxonase, a serum enzyme that has been implicated in the prevention of atherogenesis and coronary heart disease through its association with high-density-lipoprotein particles. This recent metaanalysis of 19 studies investigated the effect of the Q192R polymorphism in the PON1 gene on the risk of myocardial infarction. 25 The reported per-allele relative risk was 1.08 (95% CI 1.02-1.14), and the average allele frequency was 0.33.
Results Figure 1 shows, for each meta-analysis, a plot of log OR Gg against log OR GG . All meta-analyses show variation in the genetic effect as represented by the two log odds ratios. This might be explained by a number of factors, including sampling error, differences in the study methods and differences in the true genetic risk across study populations. In the absence of heterogeneity in the genetic model and sampling error, all studies would be expected to lie along a straight line with slope l. The solid line in Figure 1 represents the slope, l, estimated by the genetic model-free approach, while the three dotted lines corresponding to the dominant, co-dominant, and recessive genetic models are plotted for comparison. The figure allows visual identification of any outliers or influential studies. Figure 2 plots the study-specific estimates of l and their 95% bootstrap CIs, and is used to investigate whether any departures from linearity in Figure 1 are consistent with sampling error. Within individual studies l is often poorly estimated, but there is little indication in any of the meta-analyses that the genetic models are not common across studies. Table 2 summarizes the results for the different meta-analytical methods in common use; namely, separate pairwise comparisons, where log OR Gg is pooled independently of log OR GG , and methods based on assumed genetic models. In these analyses the log OR GG has been modelled as a random effect except in two cases, marked in Table 2 , where the heterogeneity of log OR GG was very close to zero. The result for the ACE example when assuming a dominant model (Table 2 ) differs from the published result, which also assumed a dominant model (Table 1) , because the main result in the original paper was based on a fixed-effect meta-analysis rather than our random effect meta-analysis. 8 The Table 3 presents the results of the genetic model-free approach, with l unbounded and bounded between 0 and 1, and of the joint pairwise comparisons. The pooled estimates of l obtained from the genetic model-free approach tend not to be very precise, In all of the examples, the AIC shows that the genetic modelfree approach fits at least as well as the joint pairwise comparisons. Since the two approaches only differ for the assumption of common l, these findings support those in Figure 2 , and suggest that there is no evidence against the assumption of common l in any of the five examples.
Under a fixed-effect assumption there is no between-study heterogeneity and so the model-free approach is exactly equivalent to the joint pairwise comparison as both models adjust for within-study correlation. For a random-effects model they give different answers because the model-free approach implies a structured covariance pattern as well as assuming a common mode of inheritance (see Appendix). The bounded analysis, in which l must lie between 0 and 1, did not alter the point estimates of any of the parameters in our examples, because the maximum likelihood estimates of l were all within the required range. The intervals for l in the bounded analysis are truncated at 0 and 1 and are based on profile likelihoods rather than approximate standard errors, which accounts for some small differences from the unbounded analysis. The bounded analysis can have an effect on the interval estimates. For instance, in the AGT example, where the fitted model is very close to recessive, the restriction on l implies that OR Gg cannot fall ,1.00 as this would either require a negative l or a protective effect of the GG genotype; the bound rules out the former and the data contradict the latter.
The AGT example appears to be close to recessive, l 5 0.01, but with the largest study pointing to a co-dominant effect, as shown in Figure 2c . If the constancy of l is doubted then joint pairwise comparisons could be used; such an analysis does not down weight the OR GG and OR Gg estimates from the largest study to the same extent and so produces larger pooled estimates. The AIC prefers the genetic model-free approach because it requires three parameters instead of four.
Discussion
When synthesizing the evidence on the association between a genetic polymorphism and a disease the main issue is the size of any association, but an important additional question is the mode of action of the gene. In practice, the estimate of the size of the association is influenced by our assumptions about the underlying genetic model. A review of the literature on meta-analysis of genetic association studies reveals how currently used approaches fail to address this issue. 6 Investigators often base their metaanalyses on the assumption of a specific genetic model and ignore their uncertainty about the mode of inheritance. Moreover, since it may be that no a priori biological evidence is available to justify the choice, different common genetic models are sometimes tested and the different results reported. Apart from the problem of multiple testing, this leaves the reader with a set of estimates and significance tests to interpret, all based on different assumptions. A number of investigators compare allele frequencies between cases and controls; however, this method yields a per-allele effect that is equivalent to assuming a co-dominant model with HardyWeinberg equilibrium. Additionally, the issue of whether the genetic model is actually common across populations does not seem to have been addressed. The results for the five meta-analysis examples show that adopting the wrong genetic model can lead to erroneous pooled estimates with deceptively high precision. The only metaanalytical approach currently in use that does not assume a common known underlying genetic model is analysis by separate pairwise comparisons, i.e. independent meta-analyses comparing genotype groups two at a time. This method ignores the correlation between the two estimated odds ratios induced by the common baseline group and thus is inefficient, as the estimates cannot 'borrow strength' from one another as they would in a multivariate meta-analysis. 14, 15 The genetic model-free approach is likely to be particularly beneficial compared with pairwise comparisons when either of the alleles is rare. Moreover, separate pairwise comparisons run into the problem of multiple testing, which becomes especially important when a polymorphism with more than two alleles is considered.
As Table 1 illustrates, published meta-analysis of genetic association studies have used a variety of methods for presenting their results. The genetic model-free approach offers a single method that could have been used in all of these examples giving a consistent presentation and avoiding the pitfall of overly strong assumptions about the genetic model or of inefficient estimates.
The genetic model-free approach provides an integrated way of synthesizing the evidence on genetic associations, which yields not only the magnitude of the genetic effect (OR), but also an indication of the operating genetic model based on the available data. The underlying genetic model is not constrained to correspond to one of the classical modes of inheritance (recessive, co-dominant, dominant), in recognition of the fact that the gene's mode of action in complex diseases might differ from that found in Mendelian traits, where the association between genotype and disease tend to be of a deterministic nature and, hence, the mode of inheritance is relatively clearly apparent. For example, a value of 0.26 for l, as in the MTHFR meta-analysis, might be interpreted in two ways:
(i) The polymorphism is recessive in some studies and co-dominant in others, so that the average result is between the two. (ii) In complex diseases, the genotype is only one of many factors acting in a complex causal cascade leading to the disease. Although, at the molecular level, the polymorphism of interest might act in a clearly Mendelian manner on some intermediate phenotype, that Mendelian 'signal' may be 'diluted' or 'distorted' when measured at the level of the final step in the cascade. Hence, l may be a more flexible and appropriate way to discuss genetic models in complex disease.
In the meta-analysis of genetic association studies there are two important types of heterogeneity that need to be addressed: heterogeneity in the genetic effect and heterogeneity in the genetic model. There are a number of reasons why we might see heterogeneity in the genetic effect, including differences in study methods and differences in the underlying genetic risk associated with gene-gene or gene-environment interactions. Heterogeneity of the genetic effect might also arise if the polymorphism under study does not act directly on the disease risk, i.e. it is not a 'functional' or 'causal' polymorphism but is simply a marker, which tends to be inherited together with the causal polymorphism (linkage disequilibrium). Populations may have different patterns of linkage disequilibrium, which lead to differences in the marker association with disease. It is important to note that causes of heterogeneity in the genetic effect will not necessarily cause heterogeneity in the genetic model. In fact, in order to act on the genetic model, interactions need to influence the disease risk in heterozygotes to a different extent to the risk in homozygotes.
The absence of heterogeneity in the genetic model is an important assumption of the genetic model-free analysis and, although this assumption is likely to hold in most cases, it still needs to be assessed. For example, the effect of genotype on allergy to pollens appears to follow different modes of inheritance for different ethnic groups and different forms of allergy. 26, 27 Although these studies are based on segregation analyses, and are relatively weak, they do raise the possibility that the mode of action may vary from study to study, perhaps owing to complex gene-environment interactions that have different impact on the disease risk in heterozygotes compared with homozygotes for the polymorphism. Thus, the assumption of a common genetic model should be checked before applying the genetic model-free approach, for instance by using the graphs presented in Figures 1  and 2 . Should this assumption be in doubt, then the best approach would be to carry out joint pairwise comparisons using a multivariate meta-analysis, where the correlations between the odds ratios for the different genotype groups are taken into account. In addition to the graphical investigation, the difference in fit, as measured by AIC, between the model with common l and the corresponding pairwise analysis offers a guide to the appropriateness of the assumption of a common genetic model. In general the random-effects model-free approach is easier to fit than the corresponding pairwise bivariate model because it contains two fewer parameters. Only in very large meta-analyses will it be possible to estimate the correlation in the heterogeneities required for the pairwise model. So, even when the assumptions of the model-free analysis are not met exactly, the model-free analysis may still be the best way of summarizing the data and obtaining CIs that are not falsely optimistic.
All of the models considered in this paper have been based on the normal approximation to the distribution of the log odds ratio. In examples where some of the studies have very few subjects within one of the genotypes, as might happen with a rarer allele, it would be better to use a multinomial likelihood. In the case of a random-effects model this adds to the complexity because of the need to numerically integrate over the random effect before maximization. Within this multinomial framework we can still use the l parameterization basic to the genetic model-free approach and interpret the results in the same way as with the normal approximation.
The results presented in this paper have been obtained using maximum likelihood methods, but a Bayesian approach with non-informative prior distributions gave very similar results to those in Tables 2 and 3 (data not shown). The choice of a Bayesian approach to implement the method might be more desirable when there is external information regarding the magnitude of the genetic effect and/or mode of inheritance, which might come from studies not included in the metaanalysis or from expert opinion. 28 When Markov chain Monte
Carlo methods are used, it also makes the generalization to multinomial likelihoods with random effects more straightforward. 29 In conclusion, we propose a new meta-analytical method based on a re-parameterization of the classical representation of genetic association studies, where the new parameters are biologically meaningful and informative. The approach makes maximum use of the information available by quantifying the magnitude of the genetic effect and estimating the genetic mode of action at the same time. The genetic model is estimated on the basis of the data rather than assumed, and this is important in all cases where no a priori knowledge about the underlying genetic model is available.
where the parameter, l, which describes the genetic model is common across studies. The heterogeneity between studies will be
The distribution of the observed data in the meta-analysis is thus
and once again the likelihood can be formed and maximized to estimate the parameters. In this model the covariance between the heterogeneities is controlled by l and can thus be estimated. It is advisable to inspect the profile likelihood of each parameter as in small meta-analyses the log-likelihood can be far from quadratic. A fixed-effects model assumes that t 5 0.
In some meta-analyses it may be appropriate to restrict l to lie in the range (0,1), that is, to exclude heterosis. In this case, the overall maximization and the profile likelihood maximizations are over the restricted range.
